TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial.
Mario E Lacouture et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.